SWX/BSLN (SWX/BSLN)

SIX Swiss Exchange: SWX/BSLN · CHF

CHF 72.9

+2.80 (+4.0%)· Recorded snapshot

Market cap	905.5M
Revenue (ttm)	247.4M
Net income (ttm)	52.4M
EPS (ttm)	CHF 4.01
Shares out	12.4M
P/E (trailing)	18.2x
P/E (forward)	13.9x
Volume	25,600
Beta	0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 247.4M
Net income (ttm): 52.4M
EPS (ttm): CHF 4.01
P/E (trailing): 18.2x
P/E (forward): 13.9x
Market cap: 905.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E13.9

P25 n/aP50 n/aP75 n/a

Trailing P/E18.2

P25 n/aP50 n/aP75 n/a

ROE39.5

P25 n/aP50 n/aP75 n/a

ROIC73.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/BSLN indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

CHF

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2026-11-18
Employees	200
Employees change	11
Employees growth	5.82%
Enterprise value	CHF 815.8M
Exchange	SIX Swiss Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2000
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CH0011432447
Last earnings date	2026-08-18
Last refreshed	2026-11-03
Market cap	CHF 905.5M
Next earnings date	2026-11-18
Price	CHF 72.90
Price currency	CHF
Sector	Healthcare
SIC code	2836
Stock price date	2026-11-03
Symbol	swx/BSLN
Website	https://www.basilea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	18.18x
Average P/E ratio (3Y)	21.62x
Average P/E ratio (5Y)	57.46x
Earnings yield	5.5%
EV/Earnings	14.91x
EV/EBIT	13.04x
EV/EBITDA	12.39x
EV/FCF	14.12x
EV/Sales	3.16x
FCF / EV yield	7.08%
FCF yield	6.35%
Forward P/E	13.94x
Graham number	34.36626
Graham upside	-52.79%
Industry forward P/E	83.4x
Lynch fair value	CHF 20.05
Lynch upside	-72.46%
P/(FCF - SBC) ratio	17.38x
P/(OCF - SBC) ratio	16.49x
P/B ratio	5.36x
P/E ratio	18.18x
P/FCF ratio	15.74x
P/OCF ratio	15.01x
P/S ratio	3.52x
Price / tangible book value	5.37x
Price/EBITDA ratio	14.29x
Sector forward P/E	19.83x
Sector P/E	34.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.2%
EBITDA margin	24.62%
Effective tax rate	10.72%
FCF margin	22.35%
Gross margin	38.51%
Operating margin	24.2%
Pretax margin	23.72%
Profit margin	21.17%
Profit per employee	CHF 261,920
Profitable quarters	5
Profitable years	4
Revenue per employee	CHF 1.2M
ROA	13.69%
ROA (5Y)	8.66%
ROCE	23.34%
ROE	39.46%
ROIC	73.48%
ROIC (5Y)	34.16%
SBC / revenue	2.1%
Tax / revenue	2.54%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-26.73%
EPS growth (Q)	67.89%
EPS growth (QoQ)	12.5%
EPS growth 3Y	-3.53%
EPS growth quarters	1
EPS growth years	0
FCF growth	-29.05%
FCF growth (Q)	-18.35%
FCF growth (QoQ)	-49.47%
FCF growth 3Y	27.08%
Gross profit growth	-13.06%
Gross profit growth (Q)	19.57%
Gross profit growth 3Y	-0.67%
Net income growth	-27.9%
Net income growth (Q)	76.85%
Net income growth (QoQ)	14.35%
Net income growth 3Y	-2.31%
Net income growth quarters	1
Net income growth years	0
OCF growth	-27.03%
OCF growth (Q)	-17.71%
OCF growth (QoQ)	-51.39%
OCF growth 3Y	26.33%
Operating income growth	-21.8%
Operating income growth (Q)	31.28%
Operating income growth 3Y	-4.1%
Revenue growth	4.74%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	-7.34%
Revenue growth 10Y	15.65%
Revenue growth 3Y	12.23%
Revenue growth 5Y	17.07%
Revenue growth quarters	1
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -2.7M
Depreciation and amortization	CHF 1M
EBIT	CHF 59.9M
EBITDA	CHF 60.9M
EPS	CHF 4.01
FCF per share	CHF 4.45
Financing cash flow	CHF -11.8M
Free cash flow	CHF 55.3M
Free cash flow minus SBC	CHF 50.1M
Gross profit	CHF 95.3M
Income taxes	CHF 6.3M
Investing cash flow	CHF -2.9M
Net cash flow	CHF 43.3M
Net income	CHF 52.4M
Operating cash flow minus SBC	CHF 52.8M
Operating income	CHF 59.9M
Revenue	CHF 247.4M
Stock-based compensation	CHF 5.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.21
Book value per share	CHF 13.09
Debt / EBITDA	1.32
Debt / equity	0.51
Debt / FCF	1.51
Interest coverage	21.08
Long-term assets	CHF 24.2M
Long-term liabilities	CHF 94.2M
Net cash (debt)	CHF 89.6M
Net cash / market cap	10.29%
Net cash growth	183.76%
Net debt / EBITDA	-1.47
Net debt / equity	-0.55
Net debt / FCF	-1.62
Piotroski F-Score	6
Property, plant and equipment	CHF 16.8M
Shareholders' equity	CHF 162.4M
Tangible book value	CHF 162.1M
Tangible book value per share	CHF 13.07
Total assets	CHF 298M
Total cash	CHF 173.1M
Total debt	CHF 83.4M
Total liabilities	CHF 135.7M
WACC	5.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.9
Current assets	CHF 273.8M
Current liabilities	CHF 41.5M
Current ratio	6.6
Inventory turnover	6.25
Net working capital	CHF 61.3M
Quick ratio	5.81
Working capital	CHF 232.3M
Working capital turnover	1.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.46%
Dividend per share	CHF 0.00
Last dividend	CHF 5.00
Shareholder yield	1.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	9.43%
10Y return CAGR	0.91%
10Y total return	9.43%
150-day SMA	CHF 58.05
15Y price change	92.88%
15Y return CAGR	5.09%
15Y total return	110.69%
1D price change	3.99%
1M price change	9.43%
1M total return	9.43%
1W price change	1.25%
1W total return	1.25%
1Y price change	57.2%
1Y return CAGR	57.25%
1Y total return	57.2%
20-day SMA	CHF 68.49
200-day SMA	CHF 57.08
20Y price change	-64.34%
20Y return CAGR	-4.56%
20Y total return	-60.67%
3M price change	40.85%
3M total return	40.85%
3Y price change	101.66%
3Y return CAGR	26.33%
3Y total return	101.66%
50-day SMA	CHF 67.26
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 75.80
52-week high date	2026-10-27
52-week low	CHF 44.70
52-week low date	2025-11-07
5Y price change	68.05%
5Y return CAGR	10.94%
5Y total return	68.05%
6M price change	34.38%
6M total return	34.38%
All-time high	CHF 284.75
All-time high date	2007-03-30
All-time low	CHF 28.55
All-time low date	2011-09-15
Average true range (ATR)	CHF 2.42
Average volume	32.2K
Beta (1Y)	0.4
Beta (2Y)	0.5
Beta (5Y)	0.32
Change from 52-week high	-3.83%
Change from 52-week low	63.09%
Change from all-time high	-74.33%
Change from all-time low	156.04%
Change from open	4.29%
Day's gap	-0.29%
Dollar volume	CHF 1.9M
High price	CHF 73.80
Low price	CHF 69.40
Monthly RSI	73.34
Open price	CHF 69.90
Position in 52-week range	79.55%
Previous close	CHF 70.10
Price vs 150-day SMA	25.94%
Price vs 20-day SMA	6.73%
Price vs 200-day SMA	28.07%
Price vs 50-day SMA	8.69%
Relative volume	0.79
RSI	63.27
Sharpe ratio	1.58
Sharpe ratio (3Y)	0.78
Sharpe ratio (5Y)	0.38
Sortino ratio	2.91
Sortino ratio (3Y)	1.54
Sortino ratio (5Y)	0.79
Volume	25.6K
Weekly RSI	74.45
YTD price change	33.64%
YTD total return	33.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11.3M
Shares change (QoQ)	2.14%
Shares change (YoY)	-1.46%
Shares held by insiders	0.67%
Shares held by institutions	26.32%
Shares outstanding	12.4M

Deeper analysis on SWX/BSLN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/BSLN report

Is a complete SWX/BSLN research report available?

No complete published report is available for swx/BSLN (SWX/BSLN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/BSLN (SWX/BSLN)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/BSLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/BSLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/BSLN

Frequently asked questions